WHO ICTRP trial
Trial of rituximab in patients with rheumatoid arthritis
SLCTR/2008/008 · Sri Lanka Clinical Trials Registry (SLCTR) · Recruiting
Key facts
| Trial ID | SLCTR/2008/008 |
|---|---|
| Public title | Trial of rituximab in patients with rheumatoid arthritis |
| Scientific title | Efficacy of low dose Rituximab with methotrexate compared to leflunomide with methotrexate in patients with refractory rheumatoid arthritis: A randomized double blind controlled clinical trial |
| Primary sponsor | A Bour & Company (Ltd) |
| Registry | Sri Lanka Clinical Trials Registry (SLCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Sri Lanka |
| Conditions | Rheumatoid arthritis refractory to standard disease modifying agents |
| Interventions | Rituximab infusions |
| Registration date | May 16, 2008 |
| Target size | 40 |
| Registry page | slctr.lk |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: